News

Keep up with our progress

Stay up to date with the latest Paratus news as we discover and develop groundbreaking therapeutics.

Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026

Validating the “Bat Engine” for Target Discovery: PS-1001, a First-in-Class Pan-Inflammasome Inhibitor Inspired by Evolutionary Biology

Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth

PS-1001: A novel Pan-Inflammasome Inhibitor targeting ASC for the treatment of Hidradenitis Suppurativa

Mining Bat Biology for Novel Therapeutic Strategies with Dr Lewis Hong of Paratus Sciences

Could bats help us fight the very diseases they give us?

Scroll to Top